| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |